Literature DB >> 30692107

Mycoplasma genitalium infection.

Ameeta E Singh1, Annie-Claude Labbé2, Ulrick Auguste2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30692107      PMCID: PMC6342694          DOI: 10.1503/cmaj.180881

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  4 in total

1.  Mycoplasma genitalium Antibiotic Resistance-Mediating Mutations in Canadian Women With or Without Chlamydia Trachomatis Infection.

Authors:  Max A Chernesky; Dan Jang; Irene Martin; Linda M N Hoang; Prenilla Naidu; Paul N Levett; John Wylie; Anu Rebbapragada; Sam Ratnam; Marek Smieja; Barbara Weinbaum; Damon Getman
Journal:  Sex Transm Dis       Date:  2017-07       Impact factor: 2.830

Review 2.  Background review for the 2016 European guideline on Mycoplasma genitalium infections.

Authors:  J S Jensen; M Cusini; M Gomberg; H Moi
Journal:  J Eur Acad Dermatol Venereol       Date:  2016-09-07       Impact factor: 6.166

3.  Mycoplasma genitalium in Toronto, Ont: Estimates of prevalence and macrolide resistance.

Authors:  Dionne Gesink; C Sarai Racey; Christine Seah; Sandra Zittermann; Leo Mitterni; Jerry Juzkiw; Heather Jamieson; Jane Greer; Sudesh Singh; Jørgen Skov Jensen; Vanessa Allen
Journal:  Can Fam Physician       Date:  2016-02       Impact factor: 3.275

4.  Prevalence and antibiotic resistance of Mycoplasma genitalium among STI clinic attendees in Western Canada: a cross-sectional analysis.

Authors:  Jennifer Gratrix; Sabrina Plitt; LeeAnn Turnbull; Petra Smyczek; Judith Brandley; Ron Scarrott; Prenilla Naidu; Penny Parker; Brenda Blore; Amy Bull; Sandy Shokoples; Lindsay Bertholet; Irene Martin; Max Chernesky; Ron Read; Ameeta Singh
Journal:  BMJ Open       Date:  2017-07-10       Impact factor: 2.692

  4 in total
  1 in total

1.  Weighing Potential Benefits and Harms of Mycoplasma genitalium Testing and Treatment Approaches.

Authors:  Lisa E Manhart; William M Geisler; Catriona S Bradshaw; Jørgen S Jensen; David H Martin
Journal:  Emerg Infect Dis       Date:  2022-08       Impact factor: 16.126

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.